AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2002 JUL 18 - (NewsRx.com & NewsRx.net) -- Authors of a research letter in the June 22, 2002, Lancet provide evidence to suggest that women with a rare twin-pregnancy disorder who proceed with the pregnancy are at no more increased risk of malignant disease than women with the disorder who choose to have their pregnancy terminated.
Hydatidiform moles are a pregnancy complication where the fetus fails to develop; instead a tumor forms which may become malignant. Hydatidiform moles arise in about 1 in 1000 to 3 in 1000 pregnancies; around 16% become malignant, requiring treatment with chemotherapy. For this reason, hydatidiform moles are removed from the womb when they are diagnosed.
Twin pregnancies with one healthy fetus and one hydatidiform mole are rare (occurring in around 1 in 20,000-100,000 twin pregnancies); women are usually advised to have the pregnancy terminated and the hydatidiform mole removed, to reduce the risk of malignant disease. Some women are reluctant to accept this advice.
Michael Seckl and colleagues from Imperial College School of Medicine, London, U.K., assessed 77 such twin pregnancies to establish the risks to ...
Source: HighBeam Research, Women with rare twin-pregnancy complication have 40% chance of...